Portal Instruments Signs Multi-Million Dollar Development Agreement to Advance PRIME NEXUS™, its Large Volume Reusable Autoinjector, to Clinical Readiness

News
2026
2025
Archive
Search news articles

December 13, 2024

Precede Biosciences Presents a Novel ER Transcriptional Dependency Index at SABCS 2024 Designed to Further Inform Use of Endocrine Therapy from a Simple Blood Test
December 11, 2024

Chroma Medicine and Nvelop Therapeutics Unite to Form nChroma Bio, Securing $75 Million to Accelerate Genetic Medicines
December 10, 2024

Rallybio Announces Promising RLYB212 and RLYB332 Preclinical Data at the 66th American Society of Hematology Annual Meeting
December 9, 2024

Vor Bio Provides Clinical Update Further Validating Approach of Using Shielded Transplants to Deliver Targeted Therapies; Receives Supportive Feedback from FDA Regarding Registrational Trial Design
December 9, 2024

Cidara Therapeutics Completes Enrollment of Phase 2b NAVIGATE Trial Evaluating CD388 for Prevention of Seasonal Influenza
December 4, 2024

Nido Biosciences Announces Publication of Collaborative Research Revealing Clinically Meaningful Endpoints for Spinal and Bulbar Muscular Atrophy
December 3, 2024

Nouscom Appoints Seasoned Executive Eckhard Niemeier as Chief Business Officer
November 21, 2024

Cidara Therapeutics Announces $105 Million Private Placement
November 21, 2024

Nouscom Completes Patient Enrollment of Randomized Phase 2 Study Evaluating NOUS-209, an Off-the-Shelf Neoantigen Immunotherapy, in dMMR/MSI Metastatic Colorectal Cancer
November 21, 2024

Rallybio Announces Initiation of Phase 2 Clinical Trial of RLYB212

1
2
3
…
9
Next Page »